Major Stake Exits in Sansera and Advanced Enzyme
On Wednesday, two entities sold their entire 11.66% stake in Sansera Engineering for Rs 750 crore through the NSE. Client Ebene and CVCIGP II Employee Ebene were the sellers. Orbimed Asia III Mauritius also sold its 9.88% stake in Advanced Enzyme Technologies for Rs 425 crore in a separate deal.
- Country:
- India
In a significant market move on Wednesday, Sansera Engineering witnessed the exit of two key stakeholders, Client Ebene and CVCIGP II Employee Ebene, who offloaded their entire 11.66% stake. The open-market transactions amounted to Rs 750 crore, facilitated through the National Stock Exchange (NSE).
In parallel, Orbimed Asia III Mauritius divested its entire 9.88% stake in Advanced Enzyme Technologies for Rs 425 crore. Shares in both companies displayed notable investor activity, reflecting the dynamic nature of current market trends.
The auto components manufacturer, Sansera Engineering, saw a total of 62.53 lakh shares transacted, while Advanced Enzyme Technologies' deal involved 1,10,53,245 shares, emphasizing the significant capital movement within these sectors.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Security Forces Engage in Intense Gunfights in Jammu & Kashmir
Russia's Air Strikes Target Kyiv Amidst Tense Conflict
Kyiv Shields Itself: Ukrainian Air Defense Halts Russian Missile and Drone Assault
Flights of Survival: The Incredible Journey of Migrating Insects
Nitin Gadkari takes charge as Union Minister of Road Transport and Highways for third consecutive time
Google News